Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Yolk sac tumour of ovary with fever and overt hypothyroidism: rare clinical presentation.

Kansara M, Yadav G, Gothwal M, Singh P.

BMJ Case Rep. 2020 Jan 9;13(1). pii: e232114. doi: 10.1136/bcr-2019-232114.

PMID:
31924708
2.

Infiltrating Myeloid Cells Drive Osteosarcoma Progression via GRM4 Regulation of IL23.

Kansara M, Thomson K, Pang P, Dutour A, Mirabello L, Acher F, Pin JP, Demicco EG, Yan J, Teng MWL, Smyth MJ, Thomas DM.

Cancer Discov. 2019 Nov;9(11):1511-1519. doi: 10.1158/2159-8290.CD-19-0154. Epub 2019 Sep 16.

PMID:
31527131
3.

Translational biology of osteosarcoma.

Kansara M, Teng MW, Smyth MJ, Thomas DM.

Nat Rev Cancer. 2014 Nov;14(11):722-35. doi: 10.1038/nrc3838. Epub 2014 Oct 16. Review.

PMID:
25319867
4.
5.

Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation.

Kansara M, Leong HS, Lin DM, Popkiss S, Pang P, Garsed DW, Walkley CR, Cullinane C, Ellul J, Haynes NM, Hicks R, Kuijjer ML, Cleton-Jansen AM, Hinds PW, Smyth MJ, Thomas DM.

J Clin Invest. 2013 Dec;123(12):5351-60. doi: 10.1172/JCI70559. Epub 2013 Nov 15.

6.

Serum catalytic Iron: A novel biomarker for coronary artery disease in patients on maintenance hemodialysis.

Rajapurkar MM, Lele SS, Malavade TS, Kansara MR, Hegde UN, Gohel KD, Gang SD, Shah SV, Mukhopadhyay BN.

Indian J Nephrol. 2013 Sep;23(5):332-7. doi: 10.4103/0971-4065.116293.

7.

Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancer.

Etemadmoghadam D, Au-Yeung G, Wall M, Mitchell C, Kansara M, Loehrer E, Batzios C, George J, Ftouni S, Weir BA, Carter S, Gresshoff I, Mileshkin L, Rischin D, Hahn WC, Waring PM, Getz G, Cullinane C, Campbell LJ, Bowtell DD.

Clin Cancer Res. 2013 Nov 1;19(21):5960-71. doi: 10.1158/1078-0432.CCR-13-1337. Epub 2013 Sep 4.

8.

Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells.

Cain JE, McCaw A, Jayasekara WS, Rossello FJ, Marini KD, Irving AT, Kansara M, Thomas DM, Ashley DM, Watkins DN.

Sarcoma. 2013;2013:608964. doi: 10.1155/2013/608964. Epub 2013 Feb 28.

9.

Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma.

Paget C, Duret H, Ngiow SF, Kansara M, Thomas DM, Smyth MJ.

Oncoimmunology. 2012 Nov 1;1(8):1313-1322.

10.

Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer.

Etemadmoghadam D, George J, Cowin PA, Cullinane C, Kansara M; Australian Ovarian Cancer Study Group, Gorringe KL, Smyth GK, Bowtell DD.

PLoS One. 2010 Nov 12;5(11):e15498. doi: 10.1371/journal.pone.0015498.

11.

Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.

Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM.

J Clin Invest. 2009 Apr;119(4):837-51. doi: 10.1172/JCI37175. Epub 2009 Mar 23.

12.

Molecular pathogenesis of osteosarcoma.

Kansara M, Thomas DM.

DNA Cell Biol. 2007 Jan;26(1):1-18. Review.

PMID:
17263592
13.

Epigenetic modifications in osteogenic differentiation and transformation.

Thomas D, Kansara M.

J Cell Biochem. 2006 Jul 1;98(4):757-69. Review.

PMID:
16598744
14.

An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development.

Cullinane C, Dorow DS, Kansara M, Conus N, Binns D, Hicks RJ, Ashman LK, McArthur GA, Thomas DM.

Cancer Res. 2005 Nov 1;65(21):9633-6.

15.

Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.

Morgan T, Atkins GJ, Trivett MK, Johnson SA, Kansara M, Schlicht SL, Slavin JL, Simmons P, Dickinson I, Powell G, Choong PF, Holloway AJ, Thomas DM.

Am J Pathol. 2005 Jul;167(1):117-28.

16.

Oncogenes modulate cell sensitivity to apoptosis induced by glucose deprivation.

Kansara M, Berridge MV.

Anticancer Res. 2004 Jul-Aug;24(4):2503-10.

17.
19.

CD95 (Fas/Apo-1)-induced apoptosis results in loss of glucose transporter function.

Berridge MV, Tan AS, McCoy KD, Kansara M, Rudert F.

J Immunol. 1996 Jun 1;156(11):4092-9.

PMID:
8666774
20.

Physiological concentrations of insulin and T3 stimulate 3T3-L1 adipocyte acyl-CoA synthetase gene transcription.

Kansara MS, Mehra AK, Von Hagen J, Kabotyansky E, Smith PJ.

Am J Physiol. 1996 May;270(5 Pt 1):E873-81.

PMID:
8967477
21.

Chromosomal localization and expressed sequence tag generation of clones from a normalized human adult thymus cDNA library.

Lamerdin JE, Athwal RS, Kansara MS, Sandhu AK, Patanjali SR, Weissman SM, Carrano AV.

Genome Res. 1995 Nov;5(4):359-67.

22.

Dinucleotide repeat polymorphism at the D6S348 locus.

Kansara MS, Athwal RS.

Hum Mol Genet. 1993 Jul;2(7):1085. No abstract available.

PMID:
8364562

Supplemental Content

Loading ...
Support Center